Revenio Group Oyj (REG1V.HE)
Makes devices and software that measure eye pressure and detect vision-threatening diseases like glaucoma and diabetic retinopathy
12.78+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-50.5%
The outlook
REG1V.HE is trading near its 52-week lows and below both short- and long-term moving averages, reflecting weak near-term momentum. Analyst coverage shows an average price target about 52% above the current price, though the stock's low StockGlow Score (21/100) suggests skepticism outweighs optimism among measured factors.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +52% vs current price
Analyst price target
~12-month · 4 analysts19.38average target+51.6% vs now
Now 12.78
Low 15.00High 23.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$371.8M
52-wk high
28.50
52-wk low
11.86
50-day avg
12.84
200-day avg
18.31
Trailing P/E
21.7